Need professional-grade analysis? Visit stockanalysis.com
$30.02B
27.60
5,298
1.30%
Beijing Tiantan Biological Products Corp Ltd (600161) trades on SHG in CNY. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at CNY14.99, down 0.53% from the previous close.
Over the past year, 600161 has traded between a low of CNY14.75 and a high of CNY21.06. The stock has lost 25.6% over this period. It is currently 28.8% below its 52-week high.
Beijing Tiantan Biological Products Corp Ltd has a market capitalization of $30.02B, with a price-to-earnings ratio of 27.60 and a dividend yield of 1.30%.
Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationally. Its products include human serum albumin; intravenous human immunoglobulin; rabies immunoglobulin; tetanus immunoglobulin; hepatitis B immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamine human immunoglobulin; human prothrombin complex concentrate; lyophilized intravenous hepatitis B immunoglobulin; human coagulation factors VIII; human fibrinogen; recombinant human coagulation factor VIII for injection; and other blood products. The company was founded in 1966 and is headquartered in Beijing, China.
Side-by-side comparison against top Healthcare peers.